Devises / CRDF
CRDF: Cardiff Oncology Inc
2.10
USD
0.02
(0.96%)
Le taux de change de CRDF a changé de 0.96% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 2.06 et à un maximum de 2.14.
Suivez la dynamique Cardiff Oncology Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CRDF Nouvelles
- AMD To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Wednesday - Arista Networks (NYSE:ANET), Advanced Micro Devices (NASDAQ:AMD)
- H.C. Wainwright lowers Cardiff Oncology stock price target on trial data
- Cardiff Oncology (CRDF) Q2 Loss Down 19%
- Why Is Cardiff Oncology Stock Trading Lower After Colorectal Cancer Data? - Cardiff Oncology (NASDAQ:CRDF)
- Avis Budget Group Posts Downbeat Earnings, Joins SoFi Technologies, Seagate And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Avis Budget Gr (NASDAQ:CAR), Cardiff Oncology (NASDAQ:CRDF)
- Why LendingClub Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), AtriCure (NASDAQ:ATRC)
- Cardiff Oncology shares plunge after Q2 earnings miss
- Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates
- Cardiff Oncology earnings missed by $0.02, revenue topped estimates
- Cardiff Oncology reports positive data from colorectal cancer trial
- Cardiff Oncology: Volatility Afoot With Onvansertib Update Near-Term (NASDAQ:CRDF)
- Cardiff Oncology stock initiated with Buy rating at Ladenburg Thalmann
- Cardiff Oncology: Trial Data Delay Unnerves Investors, But Bulls See Last Buy-Low Chance
- This Amylyx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Amylyx Pharmaceuticals (NASDAQ:AMLX), Amrize (NYSE:AMRZ)
- Cardiff Oncology stock initiated at Hold by Jefferies on early data concerns
- Cardiff Oncology appoints Roger Sidhu as new Chief Medical Officer
- 3 Best Stocks to Buy Now, 6/16/2025, According to Top Analysts - TipRanks.com
- Cardiff Oncology reports positive trial results for breast cancer treatment
- Cardiff Oncology, Inc. (CRDF) Q4 2024 Earnings Call Transcript
Range quotidien
2.06
2.14
Range Annuel
2.06
5.64
- Clôture Précédente
- 2.08
- Ouverture
- 2.12
- Bid
- 2.10
- Ask
- 2.40
- Plus Bas
- 2.06
- Plus Haut
- 2.14
- Volume
- 1.341 K
- Changement quotidien
- 0.96%
- Changement Mensuel
- -13.93%
- Changement à 6 Mois
- -50.93%
- Changement Annuel
- -8.30%
31 août, dimanche